West Pharmaceutical Services WST Income Tax
Income Tax at other companies
Other financials
Where this comes from
Reported directly by West Pharmaceutical Services in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.
The official record: West Pharmaceutical Services’s 10-Q, filed July 23, 2026, on SEC EDGAR. View the filing →
Ask your AI about West Pharmaceutical Services's income tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is West Pharmaceutical Services's income tax?
- West Pharmaceutical Services (WST) reported income tax of $32.2M in Q2 2026.
- How has West Pharmaceutical Services's income tax changed year-over-year?
- West Pharmaceutical Services's income tax increased by 6.6% year-over-year, from $30.2M to $32.2M.
- What is the long-term trend for West Pharmaceutical Services's income tax?
- Over 4 years (2021 to 2025), West Pharmaceutical Services's income tax has grown at a 3.2% compound annual growth rate (CAGR), from $107.2M to $121.6M.
- What does income tax mean?
- Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.